Cargando…

SIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer

BACKGROUND/AIMS: Sine oculis homeoprotein 1 exerts an essential role in embryonic development, and it was also identified to be reactivated in various types of mammalian cancer. The sine oculis homeoprotein 1 transcription factor was demonstrated to induce epithelial–mesenchymal transition, regulate...

Descripción completa

Detalles Bibliográficos
Autores principales: Balçık-Erçin, Pelin, Aysan, Arzu, Salık, Nazlı, Erciyas, Esma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Gastroenterology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544153/
https://www.ncbi.nlm.nih.gov/pubmed/37427884
http://dx.doi.org/10.5152/tjg.2023.22293
_version_ 1785114442183213056
author Balçık-Erçin, Pelin
Aysan, Arzu
Salık, Nazlı
Erciyas, Esma
author_facet Balçık-Erçin, Pelin
Aysan, Arzu
Salık, Nazlı
Erciyas, Esma
author_sort Balçık-Erçin, Pelin
collection PubMed
description BACKGROUND/AIMS: Sine oculis homeoprotein 1 exerts an essential role in embryonic development, and it was also identified to be reactivated in various types of mammalian cancer. The sine oculis homeoprotein 1 transcription factor was demonstrated to induce epithelial–mesenchymal transition, regulate crucial genes associated with cancer progression, and increase the oncogenic potential of cells. Therefore, the present study aimed to identify the role of sine oculis homeoprotein 1 in cancer. MATERIALS AND METHODS: Sine oculis homeoprotein 1 gene expression was tested with real-time quantitative polymerase chain reaction (PCR) in different cancer types. Sine oculis homeoprotein 1 expression was suppressed by short hairpin RNA transduction in the SNU398 hepatocellular carcinoma cell line. The effects of sine oculis homeoprotein 1 on cell proliferation, drug resistance, and sphere formation were assessed in shSIX1 cells. Immunohistochemical and in silico analyses were performed to determine the prognostic role of sine oculis homeoprotein 1 expression. RESULTS: The upregulated expression levels of sine oculis homeoprotein 1 were revealed to be correlated with the stage of the disease in breast, colon, and liver cancer, with liver cancer exhibiting the highest expression profile. Sine oculis homeoprotein 1 downregulation significantly affected cell proliferation and suppressed sorafenib resistance and sphere-forming ability. Furthermore, sine oculis homeoprotein 1 knockdown cells were identified to have decreased CD90 levels, essential for cancer stem cell properties. Finally, sine oculis homeoprotein 1 expression was a CD90-independent biomarker for the clinical prognosis of liver cancer. CONCLUSION: The results of this study showed that the knockdown of sine oculis homeoprotein 1 expression might help to prevent hepatocarcinogenesis by increasing drug sensitivity and controlling tumor sphere formation. Overall, these results indicated that sine oculis homeoprotein 1 expression might be useful as a diagnostic marker for patients with hepatocellular carcinoma.
format Online
Article
Text
id pubmed-10544153
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Turkish Society of Gastroenterology
record_format MEDLINE/PubMed
spelling pubmed-105441532023-10-03 SIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer Balçık-Erçin, Pelin Aysan, Arzu Salık, Nazlı Erciyas, Esma Turk J Gastroenterol Original Article BACKGROUND/AIMS: Sine oculis homeoprotein 1 exerts an essential role in embryonic development, and it was also identified to be reactivated in various types of mammalian cancer. The sine oculis homeoprotein 1 transcription factor was demonstrated to induce epithelial–mesenchymal transition, regulate crucial genes associated with cancer progression, and increase the oncogenic potential of cells. Therefore, the present study aimed to identify the role of sine oculis homeoprotein 1 in cancer. MATERIALS AND METHODS: Sine oculis homeoprotein 1 gene expression was tested with real-time quantitative polymerase chain reaction (PCR) in different cancer types. Sine oculis homeoprotein 1 expression was suppressed by short hairpin RNA transduction in the SNU398 hepatocellular carcinoma cell line. The effects of sine oculis homeoprotein 1 on cell proliferation, drug resistance, and sphere formation were assessed in shSIX1 cells. Immunohistochemical and in silico analyses were performed to determine the prognostic role of sine oculis homeoprotein 1 expression. RESULTS: The upregulated expression levels of sine oculis homeoprotein 1 were revealed to be correlated with the stage of the disease in breast, colon, and liver cancer, with liver cancer exhibiting the highest expression profile. Sine oculis homeoprotein 1 downregulation significantly affected cell proliferation and suppressed sorafenib resistance and sphere-forming ability. Furthermore, sine oculis homeoprotein 1 knockdown cells were identified to have decreased CD90 levels, essential for cancer stem cell properties. Finally, sine oculis homeoprotein 1 expression was a CD90-independent biomarker for the clinical prognosis of liver cancer. CONCLUSION: The results of this study showed that the knockdown of sine oculis homeoprotein 1 expression might help to prevent hepatocarcinogenesis by increasing drug sensitivity and controlling tumor sphere formation. Overall, these results indicated that sine oculis homeoprotein 1 expression might be useful as a diagnostic marker for patients with hepatocellular carcinoma. Turkish Society of Gastroenterology 2023-08-01 /pmc/articles/PMC10544153/ /pubmed/37427884 http://dx.doi.org/10.5152/tjg.2023.22293 Text en © 2023 authors https://creativecommons.org/licenses/by/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Original Article
Balçık-Erçin, Pelin
Aysan, Arzu
Salık, Nazlı
Erciyas, Esma
SIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer
title SIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer
title_full SIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer
title_fullStr SIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer
title_full_unstemmed SIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer
title_short SIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer
title_sort six1 downregulation suppresses self-renewal capacity and thy1 expression in hepatocellular carcinoma and six1 dominate the survival in liver cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544153/
https://www.ncbi.nlm.nih.gov/pubmed/37427884
http://dx.doi.org/10.5152/tjg.2023.22293
work_keys_str_mv AT balcıkercinpelin six1downregulationsuppressesselfrenewalcapacityandthy1expressioninhepatocellularcarcinomaandsix1dominatethesurvivalinlivercancer
AT aysanarzu six1downregulationsuppressesselfrenewalcapacityandthy1expressioninhepatocellularcarcinomaandsix1dominatethesurvivalinlivercancer
AT salıknazlı six1downregulationsuppressesselfrenewalcapacityandthy1expressioninhepatocellularcarcinomaandsix1dominatethesurvivalinlivercancer
AT erciyasesma six1downregulationsuppressesselfrenewalcapacityandthy1expressioninhepatocellularcarcinomaandsix1dominatethesurvivalinlivercancer